Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 5/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22802514 | 1.00 | PRSS1 (0.39) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802497 | 0.95 | PRSS1 (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802520 | 0.95 | PRSS1 (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802470 | 0.95 | NAAA (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802501 | 0.95 | NAAA (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802521 | 0.87 | PRSS1 (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802499 | 0.87 | PRSS1 (0.36) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802488 | 0.82 | NAAA (0.41) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802527 | 0.82 | NAAA (0.41) | PRSS1PRSS2PRSS3NAAADGKA | |
| SCHEMBL22802454 | 0.81 | CES2 (0.42) | PRSS1PRSS2PRSS3NAAADGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200399197-A1 | Glycol Ether Ester Compounds Useful In Lubricating Oil Compositions And Methods Of Making Same | EXXONMOBIL RES & ENG CO (US) | 2020-12-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200399197-A1 | Glycol Ether Ester Compounds Useful In Lubricating Oil Compositions And Methods Of Making Same | DEGS1, EBP, GK | PRSS1 4381/4885PRSS2 4378/4885PRSS3 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.